Sector: Cannabis
Geography: United States
COMM_CURLF
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: yahoo_fundamentals_timeseries/CURLF
| Period | Issues |
|---|---|
| 2023-03-31 Q1 | ⚠Warn 1 |
| 2023-06-30 Q2 | ✗Errors 1Warn 1 |
| 2023-09-30 Q3 | ⚠Warn 1 |
| 2023-12-31 FY | ✗Errors 1Warn 1 |
| 2023-12-31 Q4 | ✗Errors 1Warn 2 |
| 2024-03-31 Q1 | ✗Errors 1Warn 1 |
| 2024-06-30 Q2 | ⚠Warn 1 |
| 2024-09-30 Q3 | ✗Errors 1Warn 1 |
| 2024-12-31 FY | ✗Errors 1Warn 1 |
| 2024-12-31 Q4 | ✗Errors 2Warn 1 |
| 2025-03-31 Q1 | ✗Errors 1Warn 1 |
| 2025-06-30 Q2 | ✗Errors 1Warn 1 |
| 2025-09-30 Q3 | ✗Errors 1Warn 1 |
| 2025-12-31 FY | ✗Errors 1Warn 1 |
| 2025-12-31 Q4 | ✗Errors 1Warn 1 |
| 2026-03-31 Q1 | ✗Errors 3Warn 2 |
Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM USD | Operating profitM USD | D&AM USD | EBITDAM USD | Net profitM USD | Operating CFM USD | Capex + M&AM USD | AssetsM USD | EquityM USD | ROE (annualized) | Net debtM USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Q1 2026 (3M) | OK | 324.2 y/y 5.7% | 0.8 y/y -92.0% | 52.7 y/y -0.7% | 53.5 y/y -14.4% | 69.8 y/y — | 21.0 | -17.0 | 2811.6 y/y -4.6% | 821.1 y/y 0.9% | 35.4% | 459.0 | — |
| 2025-12-31 | Q4 2025 (3M) | OK | 323.4 y/y 20.6% | 10.3 y/y 201.1% | 52.7 y/y -26.5% | 63.0 y/y 2.5% | -102.1 y/y -14.7% | 42.3 | -16.4 | 2845.3 y/y -3.5% | 756.4 y/y -12.1% | -36.3% | 459.5 | — |
| 2025-09-30 | Q3 2025 (3M) | OK | 320.2 y/y -3.1% | 4.0 y/y -56.3% | 54.4 y/y -5.7% | 58.4 y/y -12.7% | -57.0 y/y — | 48.4 | -16.6 | 2883.3 y/y -6.2% | 814.8 y/y -15.0% | -9.0% | 450.9 | — |
| 2025-06-30 | Q2 2025 (3M) | OK | 314.5 y/y -8.1% | 3.3 y/y -56.5% | 55.9 y/y 8.0% | 59.2 y/y -0.2% | -65.0 y/y — | 8.5 | -15.4 | 2916.8 y/y -5.4% | 871.3 y/y -12.2% | -30.9% | 458.7 | — |
| 2025-03-31 | Q1 2025 (3M) | OK | 306.6 y/y -9.1% | 9.4 y/y -25.9% | 53.1 y/y -6.9% | 62.4 y/y -10.4% | -61.1 y/y — | 38.4 | -16.3 | 2947.4 y/y -4.3% | 814.0 y/y -20.0% | -29.2% | 439.3 | — |
| 2024-12-31 | Q4 2024 (3M) | OK | 268.2 y/y -26.1% | -10.2 y/y -153.4% | 71.7 y/y 20.8% | 61.5 y/y -21.6% | -89.1 y/y -16.5% | 39.4 | -17.9 | 2947.8 y/y -4.3% | 860.7 y/y -17.7% | -24.9% | 496.6 | — |
| 2024-09-30 | Q3 2024 (3M) | OK | 330.5 y/y -0.8% | 9.2 y/y -39.3% | 57.7 y/y 15.4% | 66.9 y/y 2.6% | -40.7 y/y — | 42.4 | -27.9 | 3074.6 y/y -4.7% | 958.9 y/y -12.2% | -5.6% | 757.7 | — |
| 2024-06-30 | Q2 2024 (3M) | OK | 342.2 y/y 1.1% | 7.5 y/y — | 51.8 y/y -9.2% | 59.3 y/y 18.8% | -48.9 y/y — | 29.4 | -24.9 | 3082.5 y/y -6.7% | 992.7 y/y -15.9% | -19.5% | 977.4 | — |
| 2024-03-31 | Q1 2024 (3M) | OK | 337.4 y/y 0.3% | 12.6 y/y -23.1% | 57.0 y/y 15.3% | 69.7 y/y 5.7% | -48.1 y/y — | 43.6 | -18.0 | 3079.9 y/y -8.4% | 1017.3 y/y -17.4% | -18.7% | 506.9 | — |
| 2023-12-31 | Q4 2023 (3M) | PARTIAL | 363.1 y/y — | 19.1 y/y — | 59.3 y/y — | 78.4 y/y — | -76.4 y/y — | 3.7 | -16.1 | 3080.7 y/y — | 1045.3 y/y — | -26.8% | 524.5 | — |
| 2023-09-30 | Q3 2023 (3M) | OK | 333.2 y/y — | 15.2 y/y — | 50.0 y/y — | 65.2 y/y — | -92.3 y/y — | 45.3 | -15.7 | 3226.5 y/y — | 1092.7 y/y — | -10.8% | 764.6 | — |
| 2023-06-30 | Q2 2023 (3M) | OK | 338.6 y/y — | -7.1 y/y — | 57.0 y/y — | 50.0 y/y — | -71.2 y/y — | 13.5 | -8.8 | 3303.4 y/y — | 1180.9 y/y — | -23.6% | 791.8 | — |
| 2023-03-31 | Q1 2023 (3M) | OK | 336.5 y/y — | 16.4 y/y — | 49.5 y/y — | 65.9 y/y — | -46.4 y/y — | 14.2 | -26.0 | 3363.1 y/y — | 1232.2 y/y — | — | 778.6 | — |
2023-12-31 Q4: Status PARTIAL (incomplete extraction or legacy OCR warnings).2023-12-31 FY: Status PARTIAL (incomplete extraction or legacy OCR warnings).Quarterly values ($ mln)
Year-over-year change
FCF ($ mln)
Net debt / cash ($ mln)
Current 1 003spot vs LTM -5%
Target market cap from conservative EBITDA and the historical EV/EBITDA
Upside: -78.0%
Main driver: Cannabis Spot Index -5% vs LTM; revenue ×0.95 vs costs ×1.04; EBITDA 234→122; at 8.4× EV/EBITDA → -78%.
Product prices — moves vs the LTM average
| Commodity | Share | Spot | LTM | 3-yr | vs LTM, $ | 3y vs LTM |
|---|---|---|---|---|---|---|
| Cannabis Spot Index (rev) | +100% | 1 003.00 | 1 060.68 | 1 055.38 | -5% | -1% |
How it is calculated — revenue → costs → EBITDA → target market cap
| 1 · Reported baseline (LTM) | |
| LTM revenue | 1 282 |
| LTM EBITDA | 234 |
| LTM cash costs (revenue − EBITDA) | 1 048 |
| 2 · Revenue projection | |
| Revenue multiplier — spot | ×0.946 (-5%) |
| = Spot revenue | 1 213 |
| Revenue multiplier — 3y price | ×0.995 (-1%) |
| = 3-year-price revenue | 1 276 |
| 3 · Costs projection | |
| Cost multiplier — spot | ×1.040 (+4%) |
| = Spot cash costs | 1 090 |
| Cost multiplier — 3y price | ×1.040 (+4%) |
| = 3-year-price cash costs | 1 090 |
| 4 · EBITDA projection (revenue − costs) | |
| = Spot EBITDA | 122 |
| = 3-year-price EBITDA | 186 |
| Conservative EBITDA = min(spot, avg) | 122 |
| 5 · Valuation → target market cap | |
| Historical EV/projected-EBITDA (75th pct) | 8.4x |
| Target EV = EV/EBITDA × conservative EBITDA | 1 029 |
| Net debt | 459 |
| Target market cap = EV − net debt | 582 |
| Current market cap | 2 650 |
Upside = target market cap ÷ current − 1 = -78.0%
Spot model vs reported — what the spot model projected (trailing-LTM base brought to the period × the period's commodity-price move) against the actual report, per reported period (quarter, half-year or full year — per the filer's calendar); amounts in USD mln. green = reported above projection, pink = below.
| Period | Act. rev | Model rev | Δ rev | Act. EBITDA | Model EBITDA | Δ EBITDA |
|---|---|---|---|---|---|---|
| 2023 Q2 | 339 | 317 | +6.9% | 50 | 33 | +50.2% |
| 2023 Q3 | 333 | 306 | +8.9% | 65 | 17 | +274.3% |
| 2023 Q4 | 355 | 332 | +6.9% | 71 | 48 | +49.1% |
| 2024 Q1 | 337 | 345 | -2.2% | 70 | 60 | +15.6% |
| 2024 Q2 | 342 | 338 | +1.3% | 59 | 54 | +10.3% |
| 2024 Q3 | 331 | 330 | +0.1% | 67 | 48 | +40.4% |
| 2024 Q4 | 268 | 321 | -16.5% | 22 | 40 | -45.6% |
| 2025 Q1 | 307 | 303 | +1.3% | 62 | 31 | +100.6% |
| 2025 Q2 | 315 | 316 | -0.6% | 59 | 50 | +17.4% |
| 2025 Q3 | 320 | 343 | -6.5% | 58 | 84 | -30.3% |
| 2025 Q4 | 323 | 337 | -3.9% | 63 | 78 | -19.4% |
| 2026 Q1 | 324 | 317 | +2.3% | 53 | 55 | -2.7% |
Projected EV/EBITDA 32.4x · target 75th pct (3y) 8.4x · LTM avg 15.4x
No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)